tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (TVRD)
NASDAQ:TVRD
US Market
Advertisement

Tvardi Therapeutics (TVRD) Technical Analysis

Compare
2,493 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
6Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Tvardi Therapeutics’s (TVRD) Moving Averages Convergence Divergence (MACD) indicator is 2.51, suggesting Tvardi Therapeutics is a Buy.
Tvardi Therapeutics’s (TVRD) 20-Day exponential moving average is 34.41, while Tvardi Therapeutics’s (TVRD) share price is $36.32, making it a Buy.
Tvardi Therapeutics’s (TVRD) 50-Day exponential moving average is 30.70, while Tvardi Therapeutics’s (TVRD) share price is $36.32, making it a Buy.

Tvardi Therapeutics (TVRD) Pivot Points

Sep 27, 2025, 02:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
33.06
34.48
35.65
37.07
38.24
39.66
40.83
Fibonacci
34.48
35.47
36.08
37.07
38.06
38.67
39.66
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Tvardi Therapeutics (TVRD) Moving Averages

Sep 27, 2025, 02:07 PM
Period
Simple
Exponential
MA5
37.00Sell
36.82Sell
MA10
36.86Sell
36.28Buy
MA20
34.10Buy
34.41Buy
MA50
29.24Buy
30.70Buy
MA100
27.71Buy
27.36Buy
MA200
21.59Buy
21.97Buy
Tvardi Therapeutics’s (TVRD) 10-Day exponential moving average is 36.28, while Tvardi Therapeutics’s (TVRD) share price is $36.32, making it a Buy.
Tvardi Therapeutics’s (TVRD) 100-Day exponential moving average is 27.36, while Tvardi Therapeutics’s (TVRD) share price is $36.32, making it a Buy.
Tvardi Therapeutics’s (TVRD) stock price is $36.32 and Tvardi Therapeutics’s (TVRD) 50-day simple moving average is 29.24, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $36.32 and Tvardi Therapeutics’s (TVRD) 100-day simple moving average is 27.71, creating a Buy signal.
Tvardi Therapeutics’s (TVRD) stock price is $36.32 and Tvardi Therapeutics’s (TVRD) 200-day simple moving average is 21.59, creating a Buy signal.

Tvardi Therapeutics (TVRD) Technical Indicators

Sep 27, 2025, 02:07 PM
Name
Value
Implied Action
RSI (14)
62.78
Neutral
STOCH (9,6)
44.87
Neutral
STOCHRSI (14)
64.61
Neutral
MACD (12,26)
2.51
Buy
ADX (14)
46.20
Neutral
Williams %R
-38.88
Buy
CCI (14)
57.30
Neutral
ATR (14)
2.52
-
Ultimate Oscillator
46.28
Neutral
ROC
22.45
Buy
Tvardi Therapeutics’s (TVRD) Relative Strength Index (RSI) is 62.78, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Trend Strength Indicator (ADX) is 46.20, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Commodity Channel Index (CCI) is 57.30, creating a Neutral signal.
Tvardi Therapeutics’s (TVRD) Price Rate of Change (ROC) is 22.45, creating a Buy signal.

FAQ

Is TVRD a Buy, Hold, or Sell?
Based on TVRD’s technical indicators, TVRD is a Buy.
    What is TVRD’s RSI (14)?
    TVRD’s RSI (14) is 62.78, which suggests TVRD is a Neutral.
      What is TVRD’s MACD?
      TVRD’s MACD is 2.51, which suggests TVRD is a Buy.
        What is TVRD’s 5-day moving average?
        TVRD’s 5-day moving average is 37.00, which suggests TVRD is a Sell.
          What is TVRD’s 20-day moving average?
          TVRD 20-day moving average is 34.10, which suggests TVRD is a Buy.
            What is TVRD’s 50-day moving average?
            TVRD’s 50-day moving average is 29.24, which suggests TVRD is a Buy.
              What is TVRD’s 200-day moving average?
              TVRD’s 200-day moving average is 21.59, which suggests TVRD is a Buy.
                What is TVRD’s Williams % R (14)?
                TVRD’s Williams % R (14) is -38.88, which suggests TVRD is a Buy.
                  What is TVRD’s CCI (14)?
                  TVRD’s CCI (14) is 57.30, which suggests TVRD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis